Minims Tropicamida Bausch + Lomb Ireland (Tropicamide)

Tropicamide, the active ingredient in Minims Tropicamida, is an anticholinergic presented as an ophthalmic solution for ocular use. It induces pupil dilation and cycloplegia to facilitate eye examinations and certain procedures. GNH USA supplies Minims Tropicamida as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Tropicamide is a mydriatic and cycloplegic agent used in ophthalmic practice to affect the pupil and accommodation. - Diagnostic eye examinations: induces pupil dilation for thorough retinal evaluation. - Anterior segment assessment: provides cycloplegia to relax accommodation during slit‑lamp examination. - Pre‑operative ophthalmic procedures: facilitates intra‑ocular surgery by maintaining a dilated pupil.

Adverse reactions may occur following ocular administration of tropicamide.

Common Side Effects: - Transient stinging or burning sensation upon instillation. - Mild ocular redness. - Temporary blurred vision. - Increased intra‑ocular pressure in susceptible patients.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma. - Allergic contact dermatitis of the eyelid or conjunctiva. - Systemic anticholinergic effects such as dry mouth, tachycardia, or urinary retention.

Tropicamide should be used with attention to patient‑specific risk factors and handling requirements. - Assess intra‑ocular pressure: avoid use in patients with narrow‑angle glaucoma. - Screen for hypersensitivity: discontinue if allergic reaction occurs. - Use with caution in children: higher risk of systemic absorption. - Avoid concurrent use with other mydriatics: may increase dilation effect. - Store at room temperature: keep in original container, protect from light and moisture.

Tropicamide may interact with other ocular or systemic agents, altering its efficacy or safety profile.

Major Interactions (Avoid): - Other anticholinergic agents: additive systemic anticholinergic effects. - Miotic agents (e.g., pilocarpine): antagonistic effect reducing dilation. - Systemic sympathomimetics (e.g., phenylephrine): may cause excessive pupil dilation and hypertension.

Moderate Interactions (Monitor Closely): - Topical ophthalmic anesthetics: may increase corneal toxicity. - Beta‑blocker eye drops: monitor intra‑ocular pressure changes.